Colorectal Cancer
|
Male
|
Age
a
|
1.38 (1.36, 1.39)
|
<.0001
|
Income
| | |
1
|
1.00
| |
2
|
0.98 (0.88, 1.10)
|
0.76
|
3
|
1.06 (0.95, 1.19)
|
0.29
|
4
|
1.01 (0.90, 1.14)
|
0.86
|
5
|
1.00 (0.88, 1.14)
|
0.98
|
Place of birth
| | |
East Asia and Pacific
|
1.00
| |
Europe and Central Asia
|
1.45 (1.32, 1.60)
|
<.0001
|
Latin America and the Caribbean
|
0.70 (0.61, 0.80)
|
<.0001
|
Middle East and North Africa
|
0.90 (0.78, 1.03)
|
0.12
|
South Asia
|
0.45 (0.40, 0.51)
|
<.0001
|
Sub-Saharan Africa
|
0.88 (0.72, 1.06)
|
0.17
|
US, Australia and New Zealand
|
0.80 (0.58, 1.09)
|
0.16
|
Length of stay
a
|
1.05 (1.02, 1.08)
|
0.0025
|
Colorectal Cancer
|
Female
|
Age
a
|
1.35 (1.33, 1.36)
|
<.0001
|
Income
| | |
1
|
1.00
| |
2
|
0.92 (0.82, 1.03)
|
0.15
|
3
|
0.93 (0.82, 1.04)
|
0.21
|
4
|
1.02 (0.90, 1.15)
|
0.81
|
5
|
0.93 (0.81, 1.06)
|
0.27
|
Place of birth
| | |
East Asia and Pacific
|
1.00
| |
Europe and Central Asia
|
1.31 (1.19, 1.45)
|
<.0001
|
Latin America and the Caribbean
|
0.89 (0.78, 1.01)
|
0.062
|
Middle East and North Africa
|
0.88 (0.74, 1.04)
|
0.12
|
South Asia
|
0.42 (0.36, 0.49)
|
<.0001
|
Sub-Saharan Africa
|
0.67 (0.54, 0.85)
|
0.0008
|
US, Australia and New Zealand
|
0.86 (0.63, 1.16)
|
0.31
|
Length of stay
a
|
1.05 (1.01, 1.08)
|
0.0046
|
Breast Cancer
|
Female
|
Age
a
|
1.19 (1.18, 1.19)
|
<.0001
|
Income
| | |
1 (lowest)
|
1.00
| |
2
|
1.00 (0.94, 1.06)
|
0.99 *
|
3
|
1.10 (1.03, 1.16)
|
0.0021
|
4
|
1.13 (1.06, 1.19)
|
0.0001
|
5 (highest)
|
1.13 (1.06, 1.20)
|
0.0004
|
Place of birth
| | |
East Asia and Pacific
|
1.00
| |
Europe and Central Asia
|
1.19 (1.12, 1.25)
|
<.0001
|
Latin America and the Caribbean
|
0.96 (0.90, 1.03)
|
0.22
|
Middle East and North Africa
|
1.29 (1.20, 1.39)
|
<.0001
|
South Asia
|
0.86 (0.81, 0.91)
|
<.0001
|
Sub-Saharan Africa
|
0.95 (0.86, 1.05)
|
0.35
|
US, Australia and New Zealand
|
1.14 (0.99, 1.30)
|
0.06
|
Length of stay
a
|
1.07 (1.05, 1.08)
|
<.0001
|